Rivaroxaban and Suicidal behavior - a phase IV clinical study of FDA data

Summary:

Suicidal behavior is reported as a side effect among people who take Rivaroxaban (rivaroxaban), especially for people who are female, 60+ old, also take Clozaril, and have Schizophrenia.

The phase IV clinical study analyzes which people have Suicidal behavior when taking Rivaroxaban. It is created by eHealthMe based on reports of 26,430 people who have side effects when taking Rivaroxaban from the FDA, and is updated regularly.

What is Rivaroxaban?

Rivaroxaban has active ingredients of rivaroxaban. It is often used in blood clots. eHealthMe is studying from 26,544 Rivaroxaban users. Check the latest studies of Rivaroxaban.

What is Suicidal behavior?

Suicidal behavior is found to be associated with 288 drugs and 449 conditions by eHealthMe. Check the latest studies of Suicidal behavior.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

26,430 people reported to have side effects when taking Rivaroxaban.
Among them, 13 people (0.05%) have Suicidal behavior.

Could Rivaroxaban cause Suicidal behavior?

Among these 13 people:

What is the gender of people who have Suicidal behavior when taking Rivaroxaban? *

female: 100 %
male: 0.0 %

What is the age of people who have Suicidal behavior when taking Rivaroxaban? *

What are other drugs people take besides Rivaroxaban? *

Zopiclone: 13 people, 100.00%
Clozaril: 13 people, 100.00%

What are other side effects people have besides Suicidal behavior? *

Pulmonary Embolism (blockage of the main artery of the lung): 13 people, 100.00%
Psychotic Disorder: 13 people, 100.00%
Pneumonia: 13 people, 100.00%
Nausea And Vomiting: 13 people, 100.00%
Leukopenia (less number of white blood cells in blood): 13 people, 100.00%
Fever: 13 people, 100.00%
Drug Ineffective: 13 people, 100.00%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 13 people, 100.00%
White Blood Cell Count Increased: 6 people, 46.15%
Thrombocytopenia (decrease of platelets in blood): 6 people, 46.15%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 13 people, 100.00%

* Approximation only. Some reports may have incomplete information.

Do you take Rivaroxaban and have Suicidal behavior?

- Check whether Suicidal behavior is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Rivaroxaban:

Rivaroxaban (26,544 reports)

Browse all side effects of Rivaroxaban:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Suicidal behavior:

Suicidal behavior (288 drugs)

Browse all the conditions that are associated with Suicidal behavior:

Suicidal behavior (449 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on rivaroxaban (the active ingredients of Rivaroxaban) and Rivaroxaban (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.